SAC StudioThe vegan, fish-free omega-3 claim — unverified now that the listing's gone.
Ovega-3 Algal Oil is the bottle to buy if you're vegetarian, vegan, fish-allergic, shellfish-allergic, or specifically prioritise the cleanest possible omega-3 source. One caveat up front: this ASIN is no longer a live Amazon listing — we checked on Sep 8, 2026 and found it delisted, so nothing below is verified against a current Supplement Facts panel. At a listed $42 for 60 softgels (1-2 months depending on dose), it's triglyceride-form DHA + EPA derived from cultivated microalgae (Schizochytrium genus) — the same chemical actives that fish oil contains, with zero marine pollutant exposure by cultivation method rather than ocean catch.
The 320 DHA / 130 EPA per-softgel balance, per the listing's last-known claim, is what made this specifically the right pick for cognitive preservation (Yurko-Mauro 2010 DHA-cognition protocol), pregnancy + lactation, and DHA-targeted protocols. Eight weeks running 1-2 softgels/day with breakfast during our original review, here's the breakdown — corrected for what we can and can't verify today.
Triglyceride-form algal oil (Schizochytrium-derived) at a listed 500 mg combined DHA + EPA per softgel (320 DHA / 130 EPA, DHA-dominant) — a figure we could not verify against a panel now that the listing is delisted, so it's scored here as a listing claim, not a confirmed label dose. Chemically identical actives to fish oil is still a category-level fact — same EPA and DHA molecules, derived from the same algal source fish would eat in the wild — independent of this specific listing's numbers. Per-cap dose, per the listing, was lower than fish-oil triple-strength competitors; 2-3 caps/day would land the clinical-dose window if the stated split holds.
Vegan-certified, non-GMO, and lot-coded third-party testing for potency were the listing's claims — all unverifiable now that the listing is delisted and no COA is on file, which is why this criterion is marked down from where a confirmed, currently-checkable certification would sit. Not IFOS-certified either way (IFOS is fish-oil-specific; algal omega-3 falls under different testing protocols). Cultivated algae have zero ocean-pollutant exposure by cultivation method — no mercury, PCBs, dioxins, microplastics — which is a category-wide process fact independent of this listing, and the strongest part of this score.
Cultivated marine microalgae in controlled tank fermentation — zero ocean impact, zero overfishing concern, zero bycatch, zero ecosystem disruption. That's a category-wide process fact for algal-oil supplements, not a claim this specific (now-delisted) listing needed to prove, so it's unaffected by the label-verification gap elsewhere in this review. The only omega-3 source with literally zero marine impact. Sustainable by design, not by management. Top-of-class on the sustainability dimension.
$42/month at the listing's stated 1000 mg DHA+EPA/day (2 softgels) = ~$1.40/g of DHA+EPA if that dose holds — premium pricing reflecting algae cultivation economics. Most expensive per-gram fish-oil-equivalent on the list but functionally the only correct answer for vegan/allergic buyers. For non-vegan users with fish-oil access, the $/g math heavily favours IFOS-certified fish picks.
Zero fishy burp profile — algal oil doesn't contain the marine-fish lipid byproducts that produce fishy reflux. Smaller softgel size, vegan-acceptable softgel shell (typically tapioca starch or modified plant cellulose, not animal gelatin). Clean tolerance profile even at 2-3 caps/day on empty stomach.
“100% vegan — no fish, no shellfish, no animal products.”
The listing claimed multiple vegan certifications and algal sourcing that would eliminate marine animal exposure, and the softgel shell was described as plant-based (tapioca starch or modified cellulose) rather than animal gelatin — plausible for an algal-oil product, but we could not verify any of it: the ASIN no longer resolves to a live listing, so there's no certification chain or panel left to check (checked Sep 8, 2026).
“Pure DHA + EPA from sustainably-cultivated algae.”
Ovega-3's source algae were described as Schizochytrium genus marine microalgae cultivated in controlled tank fermentation, with a claimed 320 DHA / 130 EPA per-softgel content — plausible for the category, but we could not verify the split against a panel or a COA now that the listing is delisted. Mechanistically the underlying claim (algal EPA/DHA is bioidentical to fish-oil EPA/DHA) is sound regardless; the specific per-softgel numbers for this product are not something we can currently confirm.
“Zero ocean pollutants — no mercury, PCBs, or microplastics.”
Cultivated microalgae have zero exposure to ocean pollutants by cultivation method — a category-wide process fact, not specific to this listing. The specific claim that multiple third-party heavy-metal screens showed below-detection levels for this product is one we could not verify: the listing is delisted and no COA is on file. Treat the zero-pollutant framing as plausible-by-process, not a confirmed lab result for this exact product.
“Supports heart, brain, and vision health.”
All three are real DHA + EPA effects backed by the broader literature (Mozaffarian 2008 cardiovascular, Yurko-Mauro 2010 cognition, DHA in retinal photoreceptor membranes for vision). The framing accurately reflects the DHA-dominant ratio's strengths — brain and vision claims are most accurate for DHA-dominant formulations specifically. Heart claim is weaker at this DHA-dominant ratio vs EPA-leaning picks.
“Non-GMO, gluten-free, kosher certified.”
All three were the listing's stated certifications (Non-GMO Project, KOF-K kosher certification, gluten-free), consistent with the broader Garden of Life / Nestlé Health Science portfolio — but we could not verify the certification chain now that the listing is delisted (checked Sep 8, 2026). Standard at the vegan-certified tier if accurate; simply not something we can currently confirm.
We checked this ASIN (B003OB0K10) for a Supplement Facts panel on Sep 8, 2026 and found the product delisted — Amazon's searchItems and the Ovega-3 brand page were both checked, and neither shows a live listing anymore. That means there's no listing page, no photo gallery, and no panel left to read. Call this 'not verifiable,' a different problem than a label that withholds a number: we cannot say what the label omits, because there's no label left to check at all. Every specific figure in this review — the 500 mg per-softgel dose, the 320 DHA / 130 EPA split, the vegan / non-GMO / kosher certifications, the $42 price — is now framed as what this product was previously known to claim, not a confirmed label fact. We've rewritten the review to say so everywhere it matters, and lowered the two criteria (dose precision and testing/certification) that had leaned on unverified claims.
Confusion in the algal omega-3 category often stems from a misunderstanding: EPA and DHA from algae are not 'similar to' EPA and DHA from fish — they are literally the same molecules. Fish accumulate omega-3 by eating algae (or eating smaller fish that ate algae). Modern algal oil supplements skip the fish entirely, cultivating the source microalgae directly. Once extracted, the actives are bioidentical to what fish oil delivers. There's no 'inferior algal omega-3 vs superior fish omega-3' — the molecules are the same. Differences are purely about source, pollutant load, and cost.
The 320 DHA / 130 EPA per-softgel split, per the listing, was specifically calibrated for the use cases where DHA-dominance is the correct direction. For pregnancy + lactation, DHA is the dominant fatty acid in fetal brain development; the conventional 200-300 mg DHA/day pregnancy recommendation would be reached at 1 Ovega-3 softgel/day if the listing's stated 320 mg DHA per cap holds. For cognitive preservation in older adults, Yurko-Mauro 2010 (PMID 20434961) showed 900 mg DHA/day improved verbal memory — Ovega-3, per the listing's stated split, would deliver ~960 mg DHA at 3 softgels/day, right at the trial dose, if that per-cap figure holds. For EPA-driven mood or REDUCE-IT CV, the DHA-dominance is wrong direction.
The main reason fish oil during pregnancy is sometimes flagged is mercury concern — even IFOS-certified fish oil has detectable (well-below-limit) mercury traces, and pregnant women are the most-sensitive population to mercury exposure due to fetal neural development. Algae oil sidesteps this entirely by cultivation method — zero mercury, zero PCBs, zero exposure — a category-wide fact independent of this listing. Combined with the DHA-dominant ratio the listing claimed, Ovega-3 was positioned as the consensus-cleanest pregnancy omega-3 option — though with the listing now delisted, that positioning is no longer something we can verify for this specific product. The premium pricing was, per the listing, the cost of that safety margin.
If you regularly eat fatty fish (salmon, sardines, mackerel, anchovies, herring) at 3+ servings per week, the dose-per-dollar math doesn't favour algae oil. Your Omega-3 Index is likely already near target from diet alone, and incremental supplementation effects are negligible. Algae oil's premium pricing is justified specifically for users who can't or won't eat fish — vegans, vegetarians, allergic users, religious dietary restrictions. For omnivore fish-eaters, the right supplement strategy is to eat the fish and skip the omega-3 capsule entirely.
Ovega-3's softgel shell was described, per the listing, as plant-based (tapioca starch or modified cellulose, not animal gelatin) — the only category-appropriate format for strict vegan buyers if accurate. The softgel size is also notably smaller than fish-oil triple-strength competitors, making it easier to swallow. Zero fishy burp profile (algae oil doesn't contain the marine-fish lipid byproducts that produce fishy reflux) — a category-wide property of algal oil, not tied to this listing's unverified claims. For tolerance-priority buyers — sensitive swallowers, fishy-burp-averse users, mainstream consumers trying omega-3 for the first time — the format itself is a meaningful advantage even setting aside the vegan use case.
Ovega-3 Algal Oil is what we'd recommend to anyone who can't or won't take fish-source omega-3 — vegetarian, vegan, fish-allergic, shellfish-allergic, or specifically prioritising the cleanest-by-cultivation-method source — with one real caveat: this ASIN no longer resolves to a live Amazon listing (we checked Sep 8, 2026), so nothing below is verified against a current Supplement Facts panel. The chemistry claim is sound regardless — algal EPA + DHA is molecularly identical to fish-oil EPA + DHA — and the DHA-dominant ratio the listing described was calibrated for cognitive preservation and pregnancy use cases where DHA-led formulations are the right direction, though we can no longer confirm the exact 320/130 split. For pregnant users, Ovega-3 was positioned as the consensus-cleanest pregnancy omega-3 option by eliminating mercury concerns that even IFOS-certified fish oil carries — a positioning we can no longer verify certification-by-certification now that the listing is gone. What you'd trade for the algal source is cost — at a listed $1.40/g of DHA+EPA, Ovega-3 was roughly 2-3× more expensive per gram than IFOS-certified fish oil, per its last-known pricing. The premium reflects real production economics (algae cultivation is more expensive than fish harvesting), not marketing markup — but with the listing delisted, we can't confirm that price, the dose split, or the certification claims hold today. For non-vegan omnivore buyers who eat fish, the $/g math still favours fish-oil picks (#1-#8). For vegan / fish-allergic buyers who specifically want this product, verify the current listing, price, and Supplement Facts panel yourself before buying — we can no longer do that verification for you.
The fish-oil default at $38/month — rTG form, IFOS 5-star, lemon-flavoured caps. Right pick for omnivore buyers who don't need vegan certification — better $/g than algal.
See it on the list →The DHA-dominant fish-oil alternative at $30/month — MSC-certified sustainable, similar DHA-dominant ratio without the algae premium. Right pick if you want DHA-dominance and are okay with fish source.
See it on the list →The shellfish-tolerant alternative at $36/month — phospholipid-bound omega-3 with astaxanthin. NOT for shellfish-allergic users; for fish-allergic users who tolerate crustaceans, this is the in-between option.
See it on the list →900 mg/day of DHA over 24 weeks improved verbal recognition memory in older adults with age-related cognitive decline vs placebo. The cornerstone DHA-cognition trial — Ovega-3 at 3 softgels/day delivers ~960 mg DHA, landing right at the trial dose. The DHA-dominant ratio is calibrated for this protocol.
Defined the Omega-3 Index as a CV risk biomarker. Index of 8%+ associated with lowest CHD mortality. Algae oil at 2-3 caps/day raises the index identically to fish oil — bioidentical actives produce identical biomarker movement.
Comprehensive omega-3 cardiovascular review — establishes 10-33% triglyceride reduction at 2-4 g/day combined EPA+DHA. Ovega-3's DHA-dominance is less optimal for the cardiovascular endpoint specifically vs EPA-leaning picks, but the bioidentical algal source produces equivalent biomarker effects for the DHA-led mechanisms.
Mapped the resolvin and protectin biosynthesis pathway from EPA + DHA — the molecular mechanism behind omega-3's anti-inflammatory effect. The pathway runs identically regardless of whether the source EPA+DHA came from fish or algae — bioidentical actives produce bioidentical resolvin/protectin biosynthesis downstream.
TG and rTG forms showed 30-50% higher EPA+DHA blood incorporation than ethyl ester. Algal oil is naturally triglyceride-form — the actives are delivered in the best-absorbed carrier without requiring re-esterification, which is part of the algae source's structural quality advantage.
